The #WMIF19 Influencers via @symplur‘s #Healthcare Hashtags http://bit.ly/WMIF19 – By Mentions and By Tweets Ranked #4: @pharma_BI and #2: @AVIVA1950, respectively. Ranked #3 via NodeXL’s Betweenness Centrality http://bit.ly/2KB6cPN
Ranked #3 via NodeXL Betweenness Centrality http://bit.ly/2KB6cPN
@phsinnovation
@evankirstel
@aviva1950
New Rankings
#4 on Mentions: @pharma_BI and
#2 on number of Tweets: @AVIVA1950
via
@symplur‘s #Healthcare Hashtags http://bit.ly/WMIF19
Third Place in Top 10 Influencers #WMIF19
Ranked #3 via NodeXL Betweenness Centrality http://bit.ly/2KB6cPN
@phsinnovation
@evankirstel
@aviva1950 Tweets, N=152
SOURCE
https://nodexlgraphgallery.org/Pages/Graph.aspx?graphID=193125
line separator end
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
SOURCE
From: SumAll <sumall@sumall.com>
Date: Sunday, April 14, 2019 at 5:05 PM
To: “<Aviva Lev-Ari>”, <PhD>, Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu>
Subject: My Weekly Digest: Week of Apr 7, 2019
Top 3 Ranked by Betweenness Centrality in Top 10 Influencers #WMIF19 @phsinnovation @evankirstel @aviva1950 – Twitter Analytics by NodeXL http://bit.ly/2KB6cPN for #WMIF19 by @PHSInnovation at World Medical Innovation Forum ARTIFICIAL INTELLIGENCE, Boston, MA USA, Monday, April 8-10, 2019
Tweets, ReTweets and Likes by @AVIVA1950 and by @pharma_BIusing @PHSInnovation and #WMIF19 during Day One, Two and Three of World Medical Innovation Forum ARTIFICIAL INTELLIGENCE, Boston, MA USA, Monday, April 8-10, 2019
LIVE Day One – World Medical Innovation Forum ARTIFICIAL INTELLIGENCE, Westin Copley Place, Boston, MA USA, Monday, April 8, 2019
LIVE Day Two – World Medical Innovation Forum ARTIFICIAL INTELLIGENCE, Boston, MA USA, Monday, April 9, 2019
LIVE Day Three – World Medical Innovation Forum ARTIFICIAL INTELLIGENCE, Boston, MA USA, Monday, April 10, 2019
This is very insightful. There is no doubt that there is the bias you refer to. 42 years ago, when I was postdocing in biochemistry/enzymology before completing my residency in pathology, I knew that there were very influential mambers of the faculty, who also had large programs, and attracted exceptional students. My mentor, it was said (although he was a great writer), could draft a project on toilet paper and call the NIH. It can’t be true, but it was a time in our history preceding a great explosion. It is bizarre for me to read now about eNOS and iNOS, and about CaMKII-á, â, ã, ä – isoenzymes. They were overlooked during the search for the genome, so intermediary metabolism took a back seat. But the work on protein conformation, and on the mechanism of action of enzymes and ligand and coenzyme was just out there, and became more important with the research on signaling pathways. The work on the mechanism of pyridine nucleotide isoenzymes preceded the work by Burton Sobel on the MB isoenzyme in heart. The Vietnam War cut into the funding, and it has actually declined linearly since.
A few years later, I was an Associate Professor at a new Medical School and I submitted a proposal that was reviewed by the Chairman of Pharmacology, who was a former Director of NSF. He thought it was good enough. I was a pathologist and it went to a Biochemistry Review Committee. It was approved, but not funded. The verdict was that I would not be able to carry out the studies needed, and they would have approached it differently. A thousand young investigators are out there now with similar letters. I was told that the Department Chairmen have to build up their faculty. It’s harder now than then. So I filed for and received 3 patents based on my work at the suggestion of my brother-in-law. When I took it to Boehringer-Mannheim, they were actually clueless.